Annie E. Ellis

FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper.

B. Monk, Amy McKee, R. Pazdur, 2017, Gynecologic oncology.

PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline.

E. Kohn, S. Lheureux, C. Muller, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bridging the Gap: A Priorities Assessment Tool to Support Shared Decision Making, Maximize Appointment Time, and Increase Patient Satisfaction in Women With Ovarian Cancer.

M. Frey, R. Kahn, E. Chapman-Davis, 2019, Journal of oncology practice.

Ovarian cancer survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum.

M. Frey, S. Blank, J. Fields, 2017, Gynecologic oncology.

Survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum

M. Frey, S. Blank, Annie E. Ellis, 2016 .

Priority assessment for women with recurrent ovarian cancer: a pilot study

M. Hammer, M. Frey, S. Blank, 2021, Gynecologic Oncology.

Impact of the COVID-19 Pandemic on Quality of Life for Women with Ovarian Cancer

M. Frey, E. Chapman-Davis, P. Christos, 2020, American Journal of Obstetrics and Gynecology.

Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic

M. Frey, E. Chapman-Davis, P. Christos, 2020, Gynecologic Oncology.

A qualitative study of ovarian cancer survivors' perceptions of endpoints and goals of care.

M. Frey, S. Blank, S. Philips, 2014, Gynecologic oncology.

Ovarian Cancer Genetics and the Implications

Annie E. Ellis, Sarah A. Cook, 2021 .